{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:58:32Z","timestamp":1791381512431,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.067","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T16:49:46Z","timestamp":1556297386000},"page":"3234-3240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep"],"prefix":"10.1016","volume":"37","author":[{"given":"S.","family":"Ortega-Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Espitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-1945","authenticated-orcid":false,"given":"A.","family":"Sahag\u00fan-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Balderas-Loaeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-5641","authenticated-orcid":false,"given":"A.","family":"Villa-Mancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Quiroz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.067_b0005","series-title":"Development of vaccines against Fasciola hepatica","first-page":"377","author":"Spithill","year":"1999"},{"key":"10.1016\/j.vaccine.2019.04.067_b0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1079\/JOH2005296","article-title":"Epidemiology of fascioliasis in human endemic areas","volume":"79","author":"Mas-Coma","year":"2005","journal-title":"J Helminthol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1751-0813.1983.tb02833.x","article-title":"The activity of triclabendazole against immature and adult Fasciola hepatica infections in sheep","volume":"60","author":"Smeal","year":"1983","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2019.04.067_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vetpar.2013.01.001","article-title":"Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep","volume":"195","author":"Ortiz","year":"2013","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpddr.2015.07.003","article-title":"First report of closantel treatment failure against Fasciola hepatica in cattle","volume":"5","author":"Novobilsk\u00fd","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.vaccine.2019.04.067_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetpar.2015.01.004","article-title":"Fasciola hepatica vaccine: we may not be there yet but we\u2019re on the right road","volume":"208","author":"Molina-Hern\u00e1ndez","year":"2015","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0035","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(96)00147-8","article-title":"Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase","volume":"14","author":"Morrison","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exppara.2015.11.002","article-title":"Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica","volume":"160","author":"Rivera","year":"2016","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0045","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.vaccine.2018.01.020","article-title":"Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica -infected and\/or vaccinated cattle and identification of protective linear B-cell epitopes","volume":"36","author":"Garza-Cuartero","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0050","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1016\/j.vaccine.2011.09.020","article-title":"The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep","volume":"29","author":"Maggioli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.1998.58.417","article-title":"Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian altiplano using purified cathepsin L cysteine proteinase","volume":"58","author":"O\u2019neill","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.04.067_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/CVI.00338-07","article-title":"Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections","volume":"15","author":"Marcilla","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2007.11.011","article-title":"Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis","volume":"158","author":"Acosta","year":"2008","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0070","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1074\/jbc.M308831200","article-title":"Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells","volume":"279","author":"Collins","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2019.04.067_b0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","article-title":"Vaccination with a CD4+ and CD8+ T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis","volume":"200","author":"Dias","year":"2018","journal-title":"Transl Res"},{"key":"10.1016\/j.vaccine.2019.04.067_b0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0264-410X(00)00165-1","article-title":"Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice","volume":"19","author":"Yang","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0085","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2016.05.053","article-title":"Evaluation of different heterologous prime\u2013boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen","volume":"34","author":"Jaramillo Ortiz","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molimm.2017.06.033","article-title":"Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection","volume":"90","author":"Shabani","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/pim.12118","article-title":"A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice","volume":"36","author":"Pinheiro","year":"2014","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S0022149X14000686","article-title":"Construction and evaluation of a chimeric protein made from Fasciola hepatica leucine aminopeptidase and cathepsin L1","volume":"90","author":"Hern\u00e1ndez-Guzm\u00e1n","year":"2016","journal-title":"J Helminthol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0105","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S003118200800471X","article-title":"Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library","volume":"135","author":"Villa-Mancera","year":"2008","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2019.04.067_b0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00436-013-3650-6","article-title":"Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1\/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats","volume":"113","author":"Villa-Mancera","year":"2014","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2019.04.067_b0115","doi-asserted-by":"crossref","first-page":"e105323","DOI":"10.1371\/journal.pone.0105323","article-title":"vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes","volume":"9","author":"Rojas-Caraballo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.04.067_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2008.10.035","article-title":"The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep","volume":"27","author":"Ha\u00e7ar\u0131z","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0125","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/IAI.67.4.1954-1961.1999","article-title":"Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep","volume":"67","author":"Piacenza","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.04.067_b0130","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.145.11.3905","article-title":"Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep","volume":"145","author":"Sexton","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0135","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/sji.12340","article-title":"Chimeric epitope vaccine from multistage antigens for lymphatic filariasis","volume":"82","author":"Anugraha","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0140","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/CVI.00164-08","article-title":"Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A","volume":"15","author":"Kaba","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0145","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1016\/j.vaccine.2010.06.039","article-title":"Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1)","volume":"28","author":"Golden","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.vetpar.2011.09.027","article-title":"Humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica","volume":"185","author":"Buffoni","year":"2012","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vetpar.2017.03.022","article-title":"Th1\/Th2 balance in the liver and hepatic lymph nodes of vaccinated and unvaccinated sheep during acute stages of infection with Fasciola hepatica","volume":"238","author":"Pacheco","year":"2017","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0160","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.067_b0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ijpara.2007.11.006","article-title":"Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps","volume":"38","author":"Gauci","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0170","doi-asserted-by":"crossref","first-page":"e0193118","DOI":"10.1371\/journal.pone.0193118","article-title":"Alunda JM. Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose","volume":"13","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.04.067_b0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcpa.2008.06.004","article-title":"A study of the liver of goats immunized with a synthetic peptide of the Sm14 antigen and challenged with Fasciola hepatica","volume":"139","author":"Zafra","year":"2008","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.parint.2009.12.005","article-title":"Immune response of goats immunised with glutathione S-transferase and experimentally challenged with Fasciola hepatica","volume":"59","author":"Buffoni","year":"2010","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2019.04.067_b0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.actatropica.2011.02.008","article-title":"Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins","volume":"118","author":"Raina","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2019.04.067_b0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vetpar.2016.05.007","article-title":"Immunization with Fasciola hepatica thioredoxin glutathione reductase failed to confer protection against fasciolosis in cattle","volume":"224","author":"Maggioli","year":"2016","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vetimm.2018.07.006","article-title":"Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14\u20133-3z and experimentally infected with Fasciola hepatica","volume":"202","author":"P\u00e9rez-Caballero","year":"2018","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-4017(02)00450-8","article-title":"Failure of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental Fasciola hepatica infection","volume":"113","author":"De Bont","year":"2003","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2019.04.067_b0205","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0264-410X(97)00289-2","article-title":"Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica","volume":"16","author":"Mulcahy","year":"1998","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:45Z","timestamp":1759401165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":41,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19305559"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}